Browse files

Dataset

Molecular effects of TYK2 inhibition

Dataset ID	Technology	Samples
EGAD00001008417	N/A	120

Dataset Description

Transcriptomic profiling of skin biopsies from psoriasis patients following treatment with deucravacitinib

Data Use Conditions

See further information on Data Use Conditions

Label	Code	Version	Modifier
health or medical or biomedical research	DUO:0000006	2019-01-07
disease specific research	DUO:0000007	2019-01-07	MONDO:0005083

Who controls access to this dataset

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:

BMS Data Sharing Request Committee
Contact person: CTT Group
Email: ctt [dot] group [at] bms [dot] com
More details: EGAC00001002450

Downloads

You don't have access to the download section.

This dataset is featured in 1 study

Studies are experimental investigations of a particular phenomenon. e.g. case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients. Click on one of the Study IDs below to find out more.

Study ID	Study Title	Study Type
EGAS00001005875	Molecular and clinical effects of selective TYK2 inhibition with deucravacitinib in psoriasis	Other

EGA Beacon